Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist

Urinary tract infections (UTI) caused by uropathogenic E. coli (UPEC) affect 150 million people annually(1,2). Despite effective antibiotic therapy, 30–50% of patients experience recurrent UTI (rUTI)(1). Additionally, the growing prevelance of UPEC resistant to last-line antibiotic treatments, and m...

詳細記述

保存先:
書誌詳細
出版年:Nature
主要な著者: Spaulding, Caitlin N., Klein, Roger D., Ruer, Ségolène, Kau, Andrew L., Schreiber, Henry L., Cusumano, Zachary T., Dodson, Karen W., Pinkner, Jerome S., Fremont, Daved H., Janetka, James W., Remaut, Han, Gordon, Jeffrey I., Hultgren, Scott J.
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5654549/
https://ncbi.nlm.nih.gov/pubmed/28614296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature22972
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料